These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38729078)

  • 1. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway.
    Liu J; Zhang Y; Wu J; Liu X; Li L; Zhang J
    Cancer Genet; 2024 Jun; 284-285():48-57. PubMed ID: 38729078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXD2-AS1 promotes malignant cell behavior in oral squamous cell carcinoma via the miR-378 g/CRABP2 axis.
    Guo S; Huang B; You Z; Luo Z; Xu D; Zhang J; Lin J
    BMC Oral Health; 2024 May; 24(1):625. PubMed ID: 38807101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data.
    Liu Z; Zhou W; Lin C; Wang X; Zhang X; Zhang Y; Yang R; Chen W; Cao W
    Aging (Albany NY); 2020 Dec; 13(2):2379-2396. PubMed ID: 33318296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HOXD-AS1 promotes oral squamous cell carcinoma by sponging miR-203a-5p.
    Zhang Y; Wang F; Yu Y
    Oral Dis; 2023 May; 29(4):1505-1512. PubMed ID: 35152529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
    Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway.
    Ni W; Xia Y; Bi Y; Wen F; Hu D; Luo L
    Aging (Albany NY); 2019 Mar; 11(5):1427-1439. PubMed ID: 30860979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXD2-AS1 Predicts Dismal Prognosis for Oral Squamous Cell Carcinoma and Regulates Cell Proliferation.
    Liang X; Chen Z; Wu G
    Cell Transplant; 2020; 29():963689720964411. PubMed ID: 33103475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis.
    Liu H; Zhang J; Luo X; Zeng M; Xu L; Zhang Q; Liu H; Guo J; Xu L
    Oncol Res; 2020 Feb; 28(1):65-73. PubMed ID: 31558183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA (lncRNA) FOXD2-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Regulating MiR-185/AKT Axis.
    Chen Z; Zhang Z; Zhao D; Feng W; Meng F; Han S; Lin B; Shi X
    Med Sci Monit; 2019 Dec; 25():9618-9629. PubMed ID: 31841454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway.
    Li C; Guo H; Xiong J; Feng B; Zhu P; Jiang W; Jiang P; Su X; Huang X
    Pathol Res Pract; 2022 Dec; 240():154219. PubMed ID: 36401978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760/E2F3 Axis.
    Hu Z; Huang L; Wang W; Guan C; Zhao Y; Liu L; Jiang X
    Dig Dis Sci; 2022 Feb; 67(2):546-558. PubMed ID: 33570683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MCM3AP-AS1 promotes proliferation, migration and invasion of oral squamous cell carcinoma cells via regulating miR-204-5p/FOXC1.
    Li H; Jiang J
    J Investig Med; 2020 Oct; 68(7):1282-1288. PubMed ID: 32690597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.
    Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z
    Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
    Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
    Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1.
    Li X; Ren H
    Oncol Rep; 2020 Oct; 44(4):1524-1538. PubMed ID: 32945498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma.
    Cao X; Luan K; Yang J; Huang Y
    Dis Markers; 2021; 2021():3138046. PubMed ID: 34457087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways.
    Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K
    Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
    Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
    Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.